Statistics for Chemomab Therapeutics Ltd. (id:6392 CMMB)

Valuation metrics

Market cap

31.11M

Enterprise value

461.49M

Trailing P/E (ttm)

-0.80

Forward P/E

-41.25

PEG ratio

-41.25

Price/Sales (ttm)

Price/Book (mrq)

2.37

Enterprise Value/Revenue

Enterprise Value/EBITDA

-28.90

Overview

Shares outstanding

18.86M

Float

169.53M

Shares short

162.90K

% Held by insiders

0.11%

% Held by institutions

0.28%

Average volume (10 days)

159.01K

Average volume (90 days)

Price summary

52-Week low

0.42

52-Week high

2.55

52-Week change

66.36%

Beta

0.30

50-Day moving average

1.56

200-Day moving average

1.11

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

March 17th, 2021

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-46.18%

Return on equity

-93.80%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-15,969,000.00

Net income to common (ttm)

-14,997,000.00

Diluted EPS (ttm)

-1.06

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

12.73M

Total cash per share (mrq)

0.04

Total debt (mrq)

360.00K

Total Debt/Equity (mrq)

3.60

Current ratio (mrq)

312.30%

Book value per share (mrq)

0.70

Cash flow

Cash flow statement

-16,130,000.00

Levered free cash flow (LFCF)

-11,364,375.00